Abstract:While it is now accepted that the gut microbiota contribute to the genotype-environment-lifestyle interactions triggering inflammatory bowel disease (IBD) episodes, efforts to identify the pathogen(s) that cause these diseases have met with limited success. The advent of culture-independent techniques for characterizing the structure and/or function of microbial communities (hereafter referred to as metagenomics) has provided new insights into the events associated with the onset, remission and recurrence of IBD. A large number of observational and/or case-control studies of IBD patients have confirmed substantive changes in gut bacterial profiles (dysbiosis) associated with disease. These types of studies have been augmented by new profiling approaches that support the identification of more ‘colitogenic' bacteria from numerically predominant taxa. Evidence of alterations in lesser abundant taxa such as the methanogenic archaea, to favor types that are more immunogenic, has also been forthcoming. Several recent longitudinal studies of patients with Crohn's disease have produced additional insights, including evidence for the role of ‘anti-inflammatory' microbiota in providing a protective effect and/or promoting remission. In summation, the implications of dysbiosis and restoration of a ‘healthy microbiota' in IBD patients requires definition beyond a taxonomic assessment of the changes in the gut microbiota during disease course. The available evidence does suggest that specific members of the gut microbiota can contribute either pro- or anti-inflammatory effects, and their ecological fitness in the large bowel affects the onset and recurrence of IBD. While metagenomics and related approaches offer the potential to provide novel and important insights into these microbiota and thereby the pathophysiology of IBD, we also need to better understand factors affecting the ecological fitness of these microbes, if new treatment of IBD patients are to be delivered.

Role of gut microbiota in infectious and inflammatory diseases

Role of the gut microbiota in immunity and inflammatory disease

The interplay between microbiota and inflammation: lessons from peritonitis and sepsis

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

The role of the microbiome in gastrointestinal inflammation

Interaction between microbiota and immunity in health and disease

[The role of gut microbiota in the regulation of the immune response]

The Role of Gut Microbiota in Infectious Diseases

Gut Microbiota Resilience Mechanisms Against Pathogen Infection and its Role in Inflammatory Bowel Disease

Role of the Microbiota in Immunity and Inflammation

The gut microbiota and gut disease

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats

Role of Gut Microbiota in Immune System Regulation

Impact of gut microbiota on immune system.

Role of intestinal microbiota and metabolites on gut homeostasis and human diseases

Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases

From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?

The Role of Microbiota on the Gut Immunology

Microbiota as key factors in inflammatory bowel disease

Microbiota and its relationship with Inflammatory Bowel Diseases: An overview